The Medical Cannabis Advisory Board approved 11 new health conditions eligible for treatment under Illinois' medical marijuana pilot program on Monday.
The board's recommendation to expand the qualifying health conditions for medical marijuana treatment to include osteoarthritis, diabetic neuropathy, post-traumatic stress disorder and other illnesses will now head to the Illinois Department of Public Health for consideration. The department could make a decision on the matter by the end of August, according to the Cannabis Association of Illinois.
Here's the full list of the new conditions approved by the Medical Cannabis Advisory Board: Anorexia nervosa; chronic post-operative pain; ehlers-danlos syndrome; irritable bowel syndrome; migraine headaches; neuro-behcet's autoimmune disease; peripheral and diabetic neuropathy; osteoarthritis; polycystic kidney disease; post-traumatic stress disorder; and superior canal dehiscence syndrome. According to the Associated Press, the rejected conditions include anxiety, diabetes and essential thrombcythemia with a JAK 2 mutation.
Illinois' pilot program for medical marijuana already covers patients with specific debilitating medical conditions, such as cancer, multiple sclerosis, and HIV/AIDS.
In response to the Medical Marijuana Advisory Board's recommendations, Sanford Stein with the Cannabis Association of Illinois said, "While this is a major milestone, this does not mean the thousands of suffering patients in Illinois will have access to this life-changing treatment."
"We are calling on the Illinois Department of Public Health and Governor [Bruce] Rauner to approve the board's recommendations so patients suffering from conditions like post-traumatic stress disorder, migraine headaches, ... chronic post-operative pain and other serious conditions can finally have access to medicine that is safe and in many cases more effective than prescription drugs," Stein said.